We use cookies to collect information, and enable our website to work properly. Please tell us whether you accept cookies by clicking the button below. If you decide not to accept cookies, our site may not work as expected and some information may not be available.
Click here for more information on cookies, including how to remove them.
SARS-CoV-2 sequencing analysis. A collaborative EQA run jointly by GenQA and UK NEQAS for Microbiology. Participants will be required to register with UK NEQAS for Microbiology for the 2025 EQA (a GenQA account will then be created). All invoicing and shipment costs will be via UK NEQAS for Microbiology.
EQA INFORMATION
EQA Code
SCOV
Submission
Variant data files
Techniques
Next Generation Sequencing (NGS), Sanger sequencing
Eligibility
All laboratories worldwide
Language
English only
EQA Accreditation
Pilot
EQA open
02 June 2025
25 August 2025
17 November 2025
02 March 2026
Testing period
6 weeks from sample distribution
OTHER INFORMATION
A collaborative EQA run jointly by GenQA and UK NEQAS for Microbiology. Participants will be required to register with UK NEQAS for Microbiology for the 2025 EQA (a GenQA account will then be created). All invoicing and shipment costs will be via UK NEQAS for Microbiology. Data collection, quality control (QC), storage and analysis to GenQA defined standards and requirements is subcontracted to a commercial company, Euformatics.
What are participants required to do?
Enrolled participants will receive details by email when an EQA is open for result submission.
Participants are expected to access the instructions and information for the cases/samples online and to analyse them according to their laboratory/centre protocols.
Participants must submit their data files by the deadline via the upload link provided by GenQA.
What can I expect as a participant?
Every participant will receive:
An Individual Laboratory/Centre Report (ILR/ICR) with educational advice for each distribution of this EQA, and an Individual Laboratory Report (ILR) for each submitted data set.
A Variant Concordance Report containing assessment of all variants submitted.
The Summary report for each distribution of this EQA which contains information regarding general findings, a summary of methodologies used, common errors, number of participants and benchmarking.
Access to a live Performance Certificate summarising your performance status for all EQAs in which you are enrolled.
Please note: EQA details may be subject to change prior to EQA distribution.
PRODUCTS
Sample type: Freeze dried inactivated SARS-CoV-2 virus (provided by UK NEQAS Microbiology)
Testing/analysis:
Sequence the SARS-CoV-2 genome.
Submit FASTA, VCF, FASTQ and BAM files from your analysed data as available.
Two samples will be sequenced per EQA run.
Conditions/Gene target(s):
Assess the quality of SARS-CoV-2 sequencing.
Any platform/technology can be used.
Number of cases: 2 samples per distribution (8 in total)
NEWSLETTER SIGN UP